APTX Aptinyx Inc

Price (delayed)

$0.4451

Market cap

$30.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

-$45.92M

Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has ...

Highlights
The company's quick ratio fell by 44% YoY but it rose by 13% QoQ
The revenue has shrunk by 100% QoQ and by 100% YoY
Aptinyx's gross profit has shrunk by 100% QoQ and by 100% YoY

Key stats

What are the main financial stats of APTX
Market
Shares outstanding
67.72M
Market cap
$30.14M
Enterprise value
-$45.92M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.39
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$80.01M
EBITDA
-$79.86M
Free cash flow
-$70.33M
Per share
EPS
-$1.18
Free cash flow per share
-$1.04
Book value per share
$1.14
Revenue per share
$0
TBVPS
$1.58
Balance sheet
Total assets
$106.65M
Total liabilities
$29.17M
Debt
$24.29M
Equity
$77.49M
Working capital
$101.79M
Liquidity
Debt to equity
0.31
Current ratio
22.49
Quick ratio
21.19
Net debt/EBITDA
0.95
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-65.9%
Return on equity
-77.6%
Return on invested capital
-540.4%
Return on capital employed
-78.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APTX stock price

How has the Aptinyx stock price performed over time
Intraday
5.47%
1 week
12.4%
1 month
-21.22%
1 year
-84.81%
YTD
-83.33%
QTD
-80.39%

Financial performance

How have Aptinyx's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$79.62M
Net income
-$80.49M
Gross margin
N/A
Net margin
N/A
The revenue has shrunk by 100% QoQ and by 100% YoY
Aptinyx's gross profit has shrunk by 100% QoQ and by 100% YoY
Aptinyx's net income has plunged by 62% YoY and by 7% from the previous quarter
The company's operating income has shrunk by 60% YoY and by 7% QoQ

Growth

What is Aptinyx's growth rate over time

Valuation

What is Aptinyx stock price valuation
P/E
N/A
P/B
0.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 31% YoY and by 6% from the previous quarter
The price to book (P/B) is 81% lower than the 5-year quarterly average of 2.0 and 77% lower than the last 4 quarters average of 1.7
The equity has declined by 48% year-on-year and by 18% since the previous quarter
The revenue has shrunk by 100% QoQ and by 100% YoY

Efficiency

How efficient is Aptinyx business performance
Aptinyx's ROE has plunged by 104% YoY and by 26% from the previous quarter
The company's return on assets has shrunk by 79% YoY and by 18% QoQ
APTX's ROIC has soared by 61% year-on-year and by 36% since the previous quarter

Dividends

What is APTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APTX.

Financial health

How did Aptinyx financials performed over time
The company's total liabilities rose by 45% QoQ
The company's quick ratio fell by 44% YoY but it rose by 13% QoQ
The debt is 69% less than the equity
APTX's debt to equity has soared by 107% QoQ
The debt has soared by 72% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.